Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases

3 minute read

Published: Wednesday, October 12, 2022 at 5:02 pm

The round will help Vita Therapeutics prepare for a human clinical trial for a treatment for a form of muscular dystrophy.